Back to UBS Group AG UBS Group AG

GPCRGPCR
Showing 8 of 13 quarters

Position history for UBS Group AGUBS Group AG's holdings in STRUCTURE THERAPEUTICS INC

UBS Group AG holds 378,986 shares of GPCR (STRUCTURE THERAPEUTICS INC), worth $20.3M as of 2026-Q2. The position was increased (+78.0% shares). GPCR represents 0.0% of UBS Group AG's portfolio.

Current Value

$20.3M

Current Shares

378,986

Total Value Change

+$18.6M

Total Shares Change

+339,906

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
378,986
+78.0%
$20.3M0.0%$53.67
43
2026-Q1
Increased
212,919
+5.2%
$10.3M0.0%$63.03
29
2025-Q4
Decreased
202,477
-2.7%
$14.1M0.0%$67.78
0
2025-Q3
Increased
208,092
+36.0%
$5.8M0.0%$25.30
35
2025-Q2
Decreased
152,981
-35.8%
$3.2M0.0%$21.08
0
2025-Q1
Decreased
238,197
-2.4%
$4.1M0.0%$19.77
0
2024-Q4
Increased
244,063
+524.5%
$6.6M0.0%$26.63
44
2024-Q3
Increased
39,080
+628.7%
$1.7M0.0%$41.75
41

Other major holders of GPCR: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used